Detalhe da pesquisa
1.
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies.
Cell
; 178(1): 216-228.e21, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-31204103
2.
Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complex.
Nature
; 565(7737): 118-121, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30542156
3.
Neutralising antibodies block the function of Rh5/Ripr/CyRPA complex during invasion of Plasmodium falciparum into human erythrocytes.
Cell Microbiol
; 21(7): e13030, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30965383
4.
Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodies.
Nature
; 515(7527): 427-30, 2014 Nov 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25132548
5.
First-in-human, Randomized, Double-blind Clinical Trial of Differentially Adjuvanted PAMVAC, A Vaccine Candidate to Prevent Pregnancy-associated Malaria.
Clin Infect Dis
; 69(9): 1509-1516, 2019 10 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30629148
6.
First-in-human use of a modular capsid virus-like vaccine platform: an open-label, non-randomised, phase 1 clinical trial of the SARS-CoV-2 vaccine ABNCoV2.
Lancet Microbe
; 4(3): e140-e148, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36681093
7.
FAS2FURIOUS: Moderate-Throughput Secreted Expression of Difficult Recombinant Proteins in Drosophila S2 Cells.
Front Bioeng Biotechnol
; 10: 871933, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35600892
8.
A cVLP-Based Vaccine Displaying Full-Length PCSK9 Elicits a Higher Reduction in Plasma PCSK9 Than Similar Peptide-Based cVLP Vaccines.
Vaccines (Basel)
; 11(1)2022 Dec 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36679847
9.
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.
Med
; 2(6): 701-719.e19, 2021 06 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34223402
10.
The roles of galactitol, galactose-1-phosphate, and phosphoglucomutase in galactose-induced toxicity in Saccharomyces cerevisiae.
Biotechnol Bioeng
; 101(2): 317-26, 2008 Oct 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18421797
11.
Structural basis for recognition of the malaria vaccine candidate Pfs48/45 by a transmission blocking antibody.
Nat Commun
; 9(1): 3822, 2018 09 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-30237518
12.
Production, quality control, stability, and potency of cGMP-produced Plasmodium falciparum RH5.1 protein vaccine expressed in Drosophila S2 cells.
NPJ Vaccines
; 3: 32, 2018.
Artigo
em Inglês
| MEDLINE | ID: mdl-30131879
13.
Comparison of functional assays used in the clinical development of a placental malaria vaccine.
Vaccine
; 35(4): 610-618, 2017 01 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-28012775
14.
Accelerating the clinical development of protein-based vaccines for malaria by efficient purification using a four amino acid C-terminal 'C-tag'.
Int J Parasitol
; 47(7): 435-446, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28153778
15.
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies.
JCI Insight
; 2(12)2017 Jun 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28614791
16.
Production of full-length soluble Plasmodium falciparum RH5 protein vaccine using a Drosophila melanogaster Schneider 2 stable cell line system.
Sci Rep
; 6: 30357, 2016 07 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-27457156
17.
The Influence of Sub-Unit Composition and Expression System on the Functional Antibody Response in the Development of a VAR2CSA Based Plasmodium falciparum Placental Malaria Vaccine.
PLoS One
; 10(9): e0135406, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26327283
18.
Transient marker system for iterative gene targeting of a prototrophic fungus.
Appl Environ Microbiol
; 73(22): 7240-5, 2007 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-17921280